mGluR
The mGluR (metabotropic glutamate receptor) is a group C GPCR and is active through an indirect metabotropic process.
Products Related to mGluR (123)
- GC16619CTEP (RO4956371)CAS: 871362-31-1Purity: >98.00%
CTEP (RO4956371) (RO 4956371) is a novel, long-acting, orally bioavailable allosteric antagonist ofmGlu5receptor withIC50of 2.2 nM, and shows > 1000-fold selectivity over other mGlu receptors.
- GC10123O-Phospho-L-serineCAS: 407-41-0Purity: >98.00%
group III metabotropic glutamate receptor agonist
- GC11459Xanthurenic acidCAS: 59-00-7Purity: >98.00%
Xanthurenic acid is an endogenous group II metabotropic glutamate receptor agonist involved in sensory transmission in the thalamus.
- GC11966O-Phospho-D-SerineCAS: 73913-63-0Purity: >98%
weak agonist of the metabotropic glutamate receptor mGluR4
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC10864 | MPEP | 96206-92-7 | >98.00% | |
MPEP is a noncompetitive, selective, potent, orally active and systemically active mGlu5 receptor antagonist, with an IC 50 of 36nM for completely inhibiting quisqualate-stimulated phosphoinositide (PI) hydrolysis. | ||||
| GC16619 | CTEP (RO4956371) | 871362-31-1 | >98.00% | |
CTEP (RO4956371) (RO 4956371) is a novel, long-acting, orally bioavailable allosteric antagonist ofmGlu5receptor withIC50of 2.2 nM, and shows > 1000-fold selectivity over other mGlu receptors. | ||||
| GC17498 | L-Glutamine | 56-85-9 | >98.00% | |
Non-essential amino acid | ||||
| GC18087 | VU 0357121 | 433967-28-3 | >99.50% | |
Novel positive allosteric modulator (PAM) of mGlu5 | ||||
| GC10123 | O-Phospho-L-serine | 407-41-0 | >98.00% | |
group III metabotropic glutamate receptor agonist | ||||
| GC10494 | ADX-47273 | 851881-60-2 | >99.00% | |
mGluR5 receptor positive allosteric modulator, potent and selective | ||||
| GC10605 | LY 354740 | 176199-48-7 | >98.00% | |
LY 354740 (LY354740) is a highly potent and selective group II (mGlu2/3) receptor agonist with IC50s of 5 and 24 nM on transfected human mGlu2 and mGlu3 receptors, respectively. | ||||
| GC11182 | LY404039 | 635318-11-5 | >98.00% | |
MGlu2 and mGlu3 receptors agonist | ||||
| GC11459 | Xanthurenic acid | 59-00-7 | >98.00% | |
Xanthurenic acid is an endogenous group II metabotropic glutamate receptor agonist involved in sensory transmission in the thalamus. | ||||
| GC11501 | TCN 238 | 125404-04-8 | >98.00% | |
Positive allosteric modulator of mGlu4 receptors | ||||
| GC11667 | VU0483605 | 1623101-11-0 | >98% | |
elective positive allosteric modulator (PAM) of mGluR1 | ||||
| GC11766 | Fenobam | 57653-26-6 | >99.50% | |
mGlu5 antagonist | ||||
| GC11871 | MTEP hydrochloride | 1186195-60-7 | >98.00% | |
A selective mGlu5a receptor antagonist | ||||
| GC11954 | mGlu2 agonist | 1311385-32-6 | >98.00% | |
| GC11966 | O-Phospho-D-Serine | 73913-63-0 | >98% | |
weak agonist of the metabotropic glutamate receptor mGluR4 | ||||
| GC12238 | Oxomemazine | 3689-50-7 | >98% | |
NULL | ||||
| GC12279 | (RS)-MCPG | 146669-29-6 | >99.50% | |
mGluR antagonist | ||||
| GC12394 | (±)-trans-ACPD | 67684-64-4 | >98.00% | |
metabotropic glutamate receptors agonist | ||||
| GC12485 | Ro 67-7476 | 298690-60-5 | >99.50% | |
positive allosteric modulator of mGlu1 receptors | ||||
| GC12510 | BINA | 866823-73-6 | >99.00% | |
BINA (BINA) is a selective human mGluR2 (hmGluR2) potentiator for the treatment of many neurological disorders. | ||||
| GC12532 | CHPG | 170846-74-9 | >98.00% | |
CHPG is a selective metabotropic glutamate receptor 5 (mGlu5) agonist. | ||||
| GC12831 | LY 367385 | 198419-91-9 | >99.00% | |
mGlu1a receptor antagonist | ||||
| GC13192 | E4CPG | 170846-89-6 | >98.00% | |
group I/group II metabotropic glutamate receptor antagonist | ||||
| GC13281 | VU 0364770 | 61350-00-3 | >99.50% | |
Positive allosteric modulator(PAM) of mGlu4 | ||||
